menu search

OPRX / OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx to Participate in Upcoming Investor Conferences
ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that management will participate in the following upcoming investor conferences: Read More
Posted: Nov 28 2022, 09:31
Author Name: GlobeNewsWire
Views: 102078

OPRX News  

OptimizeRx Corp. (OPRX) Surges 13.0%: Is This an Indication of Further Gains?

By Zacks Investment Research
October 13, 2023

OptimizeRx Corp. (OPRX) Surges 13.0%: Is This an Indication of Further Gains?

OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions more_horizontal

OptimizeRx Corporation (OPRX) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 14, 2023

OptimizeRx Corporation (OPRX) Q2 2023 Earnings Call Transcript

OptimizeRx Corporation. (NASDAQ:OPRX ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants William Febbo - Chief Executiv more_horizontal

OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET

By GlobeNewsWire
July 31, 2023

OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET

ROCHESTER, Mich., July 31, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technolo more_horizontal

OptimizeRx Aims For Growth After Swoon

By Seeking Alpha
July 21, 2023

OptimizeRx Aims For Growth After Swoon

OptimizeRx Corporation provides communication technologies between pharma firms, healthcare providers, and patients. The company has seen material ope more_horizontal

OptimizeRx Corporation (OPRX) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 10, 2023

OptimizeRx Corporation (OPRX) Q1 2023 Earnings Call Transcript

OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Will Febbo - Chief Executive Offic more_horizontal

OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 10, 2023

OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates

OptimizeRx Corp. (OPRX) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to los more_horizontal

OptimizeRx Has A Good Growth Path Ahead

By Seeking Alpha
April 3, 2023

OptimizeRx Has A Good Growth Path Ahead

OptimizeRx Corporation is an interesting company with an investment thesis based on its ability to capture a large TAM, with customers being some of t more_horizontal

OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock?

By Zacks Investment Research
March 15, 2023

OptimizeRx Corp. (OPRX) Soars 7.2%: Is Further Upside Left in the Stock?

OptimizeRx Corp. (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not more_horizontal


Search within

Pages Search Results: